The Lung Immune Prognostic Index Discriminates Survival Outcomes in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors
暂无分享,去创建一个
R. Lewinson | D. Heng | S. North | T. Cheng | D. Morris | D. G. Bebb | I. Stukalin | I. Vallerand | A. Pabani | M. Dean | D. Meyers | A. Suo